Absence of viral rebound after treatment of HIV-infected patients with didanosine and hydroxycarbamide.
Vila
J
J
Nugier
F
F
Barguès
G
G
Vallet
T
T
Peyramond
D
D
Hamedi-Sangsari
F
F
Seigneurin
J M
JM
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage / Q000627:therapeutic use*; D019384:Nucleic Acid Synthesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D019562:Viral Load
D019380:Anti-HIV Agents; D019384:Nucleic Acid Synthesis Inhibitors; D016049:Didanosine; D006918:Hydroxyurea